Nanologica AB (publ) (NICA) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello and welcome to today's conversation here at Redeye with NanoLogica's CEO Andreas Bagwani who has recently released his quarterly report and also a press release. Welcome Andreas. Thank you very much. I think before we go into this press release you released on Wednesday, maybe we can talk a little bit about the report. What was the most important thing to take with you from it? I would say that the most important thing is that we have sales and that sales is almost as big as last year. But maybe even more important is that we have worked a lot with production and production challenges have been what has kept us back. And now we are a little clearer in that we are working very intensively under Q1 and Q2 here, which will give results Q3 and forward. So I would say that it is the two factors that are the most important. Right, and if we look at the order that arrived on Wednesday, you communicate that you have delivered a production order to a customer in China for about $180,000. Can you tell us more about this order and your expectations of this customer? This is very similar to what we had last summer when we delivered about the same order, I think it was a bit smaller, to another GLP1 manufacturer in China. And I think that you can expect a similar scenario, that they might buy a little more, buy a little more, buy a little more. But this is a much, much bigger customer. And this is also a customer who evaluates more products than just this one. So I would say that strategically, if the first one was strategically important because it was the first one, then this one is much, much, much bigger. And that's why it's important. When you say evaluate more products, are you also talking about Enlab, Idun and Siv, or is it a specific saga? No, it is mainly Enlab an...